{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T01:27:07Z","timestamp":1783560427199,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.vaccine.2009.05.055","type":"journal-article","created":{"date-parts":[[2009,6,10]],"date-time":"2009-06-10T11:50:00Z","timestamp":1244634600000},"page":"4648-4655","source":"Crossref","is-referenced-by-count":45,"title":["Peptide mimotopes of rabies virus glycoprotein with immunogenic activity"],"prefix":"10.1016","volume":"27","author":[{"given":"Mehdi","family":"Houimel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koussay","family":"Dellagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.05.055_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0378-1135(90)90141-H","article-title":"From rabies to rabies-related viruses","volume":"23","author":"Bourhy","year":"1990","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0065-3527(08)00005-5","article-title":"Lyssaviruses: current trends","volume":"71","author":"Nadin-Davis","year":"2008","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2009.05.055_bib3","doi-asserted-by":"crossref","first-page":"e2057","DOI":"10.1371\/journal.pone.0002057","article-title":"Genomic diversity and evolution of the lyssaviruses","volume":"3","author":"Delmas","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2009.05.055_bib4","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1073\/pnas.83.11.3914","article-title":"Walking along the rabies genome: is the large G-L intergenic region a remnant gene?","volume":"83","author":"Tordo","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.05.055_bib5","first-page":"263","article-title":"The rabies virus genome: an overview","volume":"60","author":"Tordo","year":"1993","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2009.05.055_bib6","doi-asserted-by":"crossref","first-page":"S771","DOI":"10.1093\/clinids\/10.Supplement_4.S771","article-title":"The molecular biology of rabies viruses","volume":"10","author":"Wunner","year":"1988","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2009.05.055_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0042-6822(91)90539-N","article-title":"Membrane fusion activity, oligomerization, and assembly of the rabies virus glycoprotein","volume":"185","author":"Whitt","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.05.055_bib8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0042-6822(92)90465-2","article-title":"Rabies virus glycoprotein is a trimer","volume":"187","author":"Gaudin","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.05.055_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0168-1702(02)00267-8","article-title":"Differential stability and fusion activity of Lyssavirus glycoprotein trimers","volume":"91","author":"Desmezieres","year":"2003","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2009.05.055_bib10","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/IAI.16.3.754-759.1977","article-title":"Rabies virus glycoprotein. II. Biological and serological characterization","volume":"16","author":"Cox","year":"1973","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.055_bib11","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1099\/0022-1317-83-6-1465","article-title":"Rabies virus glycoprotein can fold in two alternative, antigenically distinct conformations depending on membrane-anchor type","volume":"83","author":"Maillard","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib12","first-page":"325","article-title":"Rabies vaccines from Pasteur's time up to experimental subunit vaccines today","volume":"14","author":"Perrin","year":"1990","journal-title":"Adv Biotechnol Processes"},{"key":"10.1016\/j.vaccine.2009.05.055_bib13","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/JVI.65.8.4198-4203.1991","article-title":"Antigenicity of rabies virus glycoprotein","volume":"65","author":"Benmansour","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.vetmic.2005.04.007","article-title":"Immunogenic and antigenic properties of recombinant soluble glycoprotein of rabies virus","volume":"108","author":"Gupta","year":"2005","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1099\/0022-1317-64-4-843","article-title":"Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies","volume":"64","author":"Lafon","year":"1983","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib16","first-page":"219","article-title":"Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies","volume":"57","author":"Lafon","year":"1984","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2009.05.055_bib17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/viro.1993.1261","article-title":"Mechanisms of rabies virus neutralization","volume":"194","author":"Flamand","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.05.055_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1348-0421.1998.tb02270.x","article-title":"functional analyses of glycoprotein of rabies virus using monoclonal antibodies","volume":"42","author":"Luo","year":"1998","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib19","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/JVI.53.3.926-934.1985","article-title":"Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein","volume":"53","author":"Seif","year":"1985","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1073\/pnas.80.1.70","article-title":"Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus","volume":"80","author":"Dietzschold","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.05.055_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0042-6822(85)90440-4","article-title":"Antigenic variants of CVS rabies virus with altered glycosylation sites","volume":"140","author":"Wunner","year":"1985","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.05.055_bib22","first-page":"271","article-title":"Rabies virus antigenicity: an overview","volume":"60","author":"Coulon","year":"1993","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2009.05.055_bib23","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1128\/JVI.64.8.3804-3809.1990","article-title":"Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine","volume":"64","author":"Dietzschold","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1348-0421.1995.tb03258.x","article-title":"Mapping and characterization of a sequential epitope on the rabies virus glycoprotein which is recognized by a neutralizing monoclonal antibody, RG719","volume":"39","author":"Ni","year":"1995","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib25","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1099\/vir.0.80362-0","article-title":"Identification of a conserved linear epitope at the N terminus of the rabies virus glycoprotein","volume":"85","author":"Mansfield","year":"2004","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib26","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1099\/0022-1317-74-8-1539","article-title":"Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein","volume":"74","author":"Van der Heijden","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0168-1702(97)00080-4","article-title":"A virus-neutralizing epitope on the glycoprotein of rabies virus that contains Trp251 is a linear epitope","volume":"51","author":"Luo","year":"1997","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2009.05.055_bib28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/JVI.44.2.595-602.1982","article-title":"Antigenic structure of rabies virus glycoprotein: ordering and immunological characterization of the large CNBr cleavage fragments","volume":"44","author":"Dietzschold","year":"1982","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1099\/0022-1317-77-2-339","article-title":"Immunodominant epitopes defined by a yeast-expressed library of random fragments of the rabies virus glycoprotein map outside major antigenic sites","volume":"77","author":"Lafay","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib30","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1016\/j.vaccine.2005.04.009","article-title":"A mimotope peptide-based anti-cancer vaccine selected by BAT monoclonal antibody","volume":"23","author":"Hardy","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.05.055_bib31","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.4049\/jimmunol.181.9.6644","article-title":"Immunization with a mimotope of GD2 ganglioside induces CD8+ T cells that recognize cell adhesion molecules on tumor cells","volume":"181","author":"Wierzbicki","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jviromet.2006.10.015","article-title":"Identification of hepatitis A virus mimotopes by phage display, antigenicity and immunogenicity","volume":"140","author":"Larralde","year":"2007","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2009.05.055_bib33","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1016\/j.vaccine.2007.03.018","article-title":"Development of a multi-mimotope peptide as a vaccine immunogen for infectious bursal disease virus","volume":"25","author":"Wang","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.05.055_bib34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ymeth.2003.08.010","article-title":"Allergen mimotopes","volume":"32","author":"Riemer","year":"2004","journal-title":"Methods"},{"key":"10.1016\/j.vaccine.2009.05.055_bib35","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0264-410X(97)00072-8","article-title":"Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration","volume":"15","author":"Delmastro","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.05.055_bib36","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1096\/fj.00-0898com","article-title":"Dissection of the humoral immune response toward an immunodominant epitope of HIV: a model for the analysis of antibody diversity in HIV+ individuals","volume":"15","author":"Enshell-Seijffers","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.vaccine.2009.05.055_bib37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.cr.7290087","article-title":"A mimotope of pre-S2 region of surface antigen of viral hepatitis B screened by phage display","volume":"11","author":"Zhang","year":"2001","journal-title":"Cell Res"},{"key":"10.1016\/j.vaccine.2009.05.055_bib38","first-page":"446","article-title":"Newly characterized species- specific immunogenic Chlamydophila pneumoniae peptide reactive with murine monoclonal and human serum antibodies","volume":"9","author":"Marston","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib39","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1128\/IAI.73.1.444-452.2005","article-title":"Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections","volume":"73","author":"Beckmann","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.055_bib40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1574-695X.1999.tb01392.x","article-title":"Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease","volume":"26","author":"Moe","year":"1999","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib41","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0264-410X(00)00397-2","article-title":"A DNA vaccine encoding a peptide mimic of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in Balb\/c mice","volume":"19","author":"Lesinski","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.05.055_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cellimm.2006.05.005","article-title":"Mimotope vaccination for epitope-specific induction of anti-CD20 antibodies","volume":"239","author":"Li","year":"2006","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib43","first-page":"65","article-title":"Phage-displayed mimotopes elicit monoclonal antibodies specific for a malaria vaccine candidate","volume":"379","author":"Demangel","year":"1998","journal-title":"Biol Chem"},{"key":"10.1016\/j.vaccine.2009.05.055_bib44","doi-asserted-by":"crossref","first-page":"11455","DOI":"10.1073\/pnas.97.21.11455","article-title":"Immunization against Alzheimer's beta -amyloid plaques via EFRH phage administration","volume":"97","author":"Frenkel","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.05.055_bib45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/IAI.73.1.325-333.2005","article-title":"A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice","volume":"73","author":"Buchwald","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.055_bib46","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1093\/jnci\/dji373","article-title":"Vaccination with cetuximab mimotopes and biological properties of induced anti- epidermal growth factor receptor antibodies","volume":"97","author":"Riemer","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.vaccine.2009.05.055_bib47","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/S0264-410X(00)00561-2","article-title":"Induction of hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamentous phage display vaccine","volume":"19","author":"Wan","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.05.055_bib48","first-page":"206","article-title":"Additional thoughts on human rabies vaccination","volume":"229","author":"Rupprecht","year":"2006","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2009.05.055_bib49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0092-1157(87)90040-0","article-title":"Human rabies immunoglobulin assayed by the rapid fluorescent focus inhibition test suppresses active rabies immunization","volume":"15","author":"Gluck","year":"1987","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2009.05.055_bib50","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1046\/j.1432-1327.1999.00430.x","article-title":"New inhibitors of Helicobacter pylori urease holoenzyme selected from phage-displayed peptide libraries","volume":"262","author":"Houimel","year":"1999","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2009.05.055_bib51","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.05.055_bib52","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.1696028","article-title":"Searching for peptide ligands with an epitope library","volume":"249","author":"Scott","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2009.05.055_bib53","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0161-5890(86)90081-7","article-title":"A priori delineation of a peptide which mimics a discontinuous antigenic determinant","volume":"23","author":"Geysen","year":"1986","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-1119(93)90151-R","article-title":"Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3","volume":"128","author":"Hoess","year":"1993","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2009.05.055_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1389450043490668","article-title":"Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics","volume":"5","author":"Wang","year":"2004","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.vaccine.2009.05.055_bib56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00063030-200721030-00002","article-title":"Epitope mapping: the first step in developing epitope-based vaccines","volume":"21","author":"Gershoni","year":"2007","journal-title":"BioDrugs"},{"key":"10.1016\/j.vaccine.2009.05.055_bib57","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3748\/wjg.v10.i11.1583","article-title":"Selection of a peptide mimicking neutralization epitope of hepatitis E virus with phage peptide display technology","volume":"10","author":"Gu","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib58","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.4049\/jimmunol.178.7.4417","article-title":"Peptide mimics of the group B meningococcal capsule induce bactericidal and protective antibodies after immunization","volume":"178","author":"Lo Passo","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.05.055_bib59","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1017\/S003118200800471X","article-title":"Induction of immunity in sheep to Fasciola hepatica with mimotopes of cathepsin L selected from a phage display library","volume":"135","author":"Villa-Mancera","year":"2008","journal-title":"Parasitology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09007877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09007877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T13:02:10Z","timestamp":1589893330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09007877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":59,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0264410X09007877"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.05.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}